[
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "summary": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=ee35092899f65736cd14c320a99ceb375916366a6122c5f44915ae2d50968726",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752079080,
      "headline": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "id": 135861139,
      "image": "",
      "related": "VRTX",
      "source": "MarketWatch",
      "summary": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=ee35092899f65736cd14c320a99ceb375916366a6122c5f44915ae2d50968726"
    }
  },
  {
    "ts": null,
    "headline": "Vertex: Latest Casgevy Data Highlights Efficacy Amid Slow Commercial Launch",
    "summary": "Vertex: Latest Casgevy Data Highlights Efficacy Amid Slow Commercial Launch",
    "url": "https://finnhub.io/api/news?id=2a248981108ab63a64067ef14912336ce6fd95816fee867570b4058e117ebaf0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752073764,
      "headline": "Vertex: Latest Casgevy Data Highlights Efficacy Amid Slow Commercial Launch",
      "id": 135837433,
      "image": "",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=2a248981108ab63a64067ef14912336ce6fd95816fee867570b4058e117ebaf0"
    }
  },
  {
    "ts": null,
    "headline": "Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers",
    "summary": "Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the disease worldwide, a toll that is projected to rise in the coming decades (https://ibn.fm/dyQrw). By 2050, the American Cancer Society estimates that annual cancer diagnoses will reach 35 million. While advances in treatment have improved outcomes for some patients, the demand for more effective therapies remains urgent — and the opportunity for innovation and market impact is signif",
    "url": "https://finnhub.io/api/news?id=74640673d56ce7a579d3baf288d68999fdac46578e794ab44094c76e555a66b0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752064200,
      "headline": "Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers",
      "id": 135834488,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the disease worldwide, a toll that is projected to rise in the coming decades (https://ibn.fm/dyQrw). By 2050, the American Cancer Society estimates that annual cancer diagnoses will reach 35 million. While advances in treatment have improved outcomes for some patients, the demand for more effective therapies remains urgent — and the opportunity for innovation and market impact is signif",
      "url": "https://finnhub.io/api/news?id=74640673d56ce7a579d3baf288d68999fdac46578e794ab44094c76e555a66b0"
    }
  }
]